President of Kyoto Prefectural University of Medicine Reprimanded Over Diovan Scandal, Diovan Study Chief Investigator Returns Retirement Allowance

Kyoto Prefectural Public University Corporation and Kyoto Prefectural University of Medicine on October 11 reprimanded the university president and issued a written warning to the vice president over a clinical study scandal involving the hypertension drug Diovan (valsartan). The university...read more